Table I.

Preoperative Characteristics of Patients with Carotid Stenosis undergoing TCAR and CEA

	TCAR N = 1,182 (%)	CEA N = 10,797 (%)	P-value
Age, median (IQR)	74 (66–79)	71 (64–77)	<.001
Male	63	60	.10
White	91	89	0.02
BMI, median (IQR)	28 (24–32)	28 (25–32)	.73
Coronary Artery Disease	55	28	<.001
CHF	20	11	<.001
Hypertension	91	89	.09
COPD	29	23	<.001
Diabetes	37	36	.50
Chronic Kidney Disease	39	34	.001
Dialysis Dependence	2.0	0.9	.001
Prior Limb Amputation	2.9	0.8	<.001
Smoking History			<.01
Never	23	27
Prior	52	48
Current	26	26
Preoperative Medications
Aspirin	90	82	<.001
Platelet inhibitor	86	35	<.001
Statins	88	81	<.001
Beta Blockers	57	53	<.01
Anticoagulants	14	9.9	<.001
ACE inhibitors	54	53	0.7
Ambulatory Status			<.001
Ambulatory	96	90
Ambulation with assistance	3.8	9.1
Wheelchair	0.0	1.3
Bedridden	0.2	0.1
Insurance			<.001
Medicare	67	57
Medicaid	3.5	4.2
Private	30	39
Transfer Status			<.01
None	94	96
Hospital	6.2	4.1
Rehabilitation	0.3	0.4

ACE, angiotensin converting enzyme; BMI, body mass index; CEA, carotid endarterectomy; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; IQR, interquartile range; TCAR, transcarotid artery revascularization. Bolded values indicate statistical significance at P < .05.